Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Predictors of Outcomes of Living Kidney Donation: Impact of Sex, Age and Preexistent Hypertension.

Chatzikyrkou C, Scurt FG, Clajus C, Roumeliotis S, Mertens PR, Haller H, Blume C, Liakopoulos V.

Transplant Proc. 2019 Mar;51(2):396-404. doi: 10.1016/j.transproceed.2019.01.015. Epub 2019 Jan 4.

PMID:
30879551
2.

Pros and cons of gastric bypass surgery in individuals with obesity and type 2 diabetes: nationwide, matched, observational cohort study.

Liakopoulos V, Franzén S, Svensson AM, Miftaraj M, Ottosson J, Näslund I, Gudbjörnsdottir S, Eliasson B.

BMJ Open. 2019 Jan 15;9(1):e023882. doi: 10.1136/bmjopen-2018-023882.

3.

Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence?

Liakopoulos V, Roumeliotis S, Bozikas A, Eleftheriadis T, Dounousi E.

Oxid Med Cell Longev. 2019 Jan 15;2019:9109473. doi: 10.1155/2019/9109473. eCollection 2019. Review.

4.

Aspergillosis in immunocompromised patients with haematological malignancies.

Gletsou E, Ioannou M, Liakopoulos V, Tsiambas E, Ragos V, Stefanidis I.

J BUON. 2018 Dec;23(7):7-10.

PMID:
30722105
5.

Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review.

Roumeliotis S, Dounousi E, Eleftheriadis T, Liakopoulos V.

Int J Mol Sci. 2019 Feb 1;20(3). pii: E628. doi: 10.3390/ijms20030628. Review.

6.

Remission of nephrotic syndrome after resolution of renal artery stenosis in a patient with a single functional kidney.

Schiefer J, Chatzikyrkou C, Mertens PR, Liakopoulos V.

Clin Nephrol. 2019 Jan 21. doi: 10.5414/CN109542. [Epub ahead of print] No abstract available.

PMID:
30663976
7.

Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension.

Loutradis C, Bikos A, Raptis V, Afkou Z, Tzanis G, Pyrgidis N, Panagoutsos S, Pasadakis P, Balaskas E, Zebekakis P, Liakopoulos V, Papagianni A, Parati G, Sarafidis P.

Hypertens Res. 2019 Jan 8. doi: 10.1038/s41440-018-0194-2. [Epub ahead of print]

PMID:
30622317
8.

Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions.

Georgianos PI, Liakopoulos V, Zebekakis PE.

J Clin Hypertens (Greenwich). 2019 Feb;21(2):249-251. doi: 10.1111/jch.13468. Epub 2018 Dec 24. No abstract available.

9.

Energy handling in renal tubular epithelial cells of the hamster, a native hibernator, under warm anoxia or reoxygenation.

Eleftheriadis T, Pissas G, Antoniadi G, Golfinopoulos S, Liakopoulos V, Stefanidis I.

Biomed Rep. 2018 Dec;9(6):503-510. doi: 10.3892/br.2018.1157. Epub 2018 Oct 12.

10.

Accuracy of a Newly-Introduced Oscillometric Device for the Estimation of Arterial Stiffness Indices in Patients on Peritoneal Dialysis: A Preliminary Validation Study.

Vaios V, Georgianos PI, Pikilidou MI, Eleftheriadis T, Zarogiannis S, Papagianni A, Zebekakis PE, Liakopoulos V.

Adv Perit Dial. 2018 Nov;34(2018):24-31.

PMID:
30480533
11.

Screening for renal cell carcinoma in dialysis patients.

Liakopoulos V, Eleftheriadis T, Mertens PR.

Kidney Int. 2018 Dec;94(6):1238. doi: 10.1016/j.kint.2018.08.032. No abstract available.

PMID:
30466567
12.

Cell Death Patterns Due to Warm Ischemia or Reperfusion in Renal Tubular Epithelial Cells Originating from Human, Mouse, or the Native Hibernator Hamster.

Eleftheriadis T, Pissas G, Antoniadi G, Liakopoulos V, Stefanidis I.

Biology (Basel). 2018 Nov 15;7(4). pii: E48. doi: 10.3390/biology7040048.

13.

Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report.

Liakopoulos V, Georgianos PI, Demirtzi P, Vaios V, Kalathas T, Zebekakis PE.

BMC Nephrol. 2018 Oct 25;19(1):293. doi: 10.1186/s12882-018-1071-6.

14.

The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis.

Stefanidis I, Tziastoudi M, Tsironi EE, Dardiotis E, Tachmitzi SV, Fotiadou A, Pissas G, Kytoudis K, Sounidaki M, Ampatzis G, Mertens PR, Liakopoulos V, Eleftheriadis T, Hadjigeorgiou GM, Santos M, Zintzaras E.

Ren Fail. 2018 Nov;40(1):561-576. doi: 10.1080/0886022X.2018.1496931.

15.

Unrecognized juvenile nephropathic cystinosis.

Schiefer J, Zenker M, Gröne HJ, Chatzikyrkou C, Mertens PR, Liakopoulos V.

Kidney Int. 2018 Nov;94(5):1027. doi: 10.1016/j.kint.2018.06.001. No abstract available.

PMID:
30348293
16.

A Comparative Study of Short-Term Blood Pressure Variability in Hemodialysis Patients with and without Intradialytic Hypertension.

Bikos A, Angeloudi E, Memmos E, Loutradis C, Karpetas A, Ginikopoulou E, Panagoutsos S, Pasadakis P, Liakopoulos V, Papagianni A, Sarafidis P.

Am J Nephrol. 2018;48(4):295-305. doi: 10.1159/000493989. Epub 2018 Oct 22.

PMID:
30347395
17.

Assessment and Management of Hypertension among Patients on Peritoneal Dialysis.

Vaios V, Georgianos PI, Liakopoulos V, Agarwal R.

Clin J Am Soc Nephrol. 2018 Oct 19. pii: CJN.07480618. doi: 10.2215/CJN.07480618. [Epub ahead of print] Review.

PMID:
30341090
18.

Oxidative Stress and the Kidney in the Space Environment.

Pavlakou P, Dounousi E, Roumeliotis S, Eleftheriadis T, Liakopoulos V.

Int J Mol Sci. 2018 Oct 15;19(10). pii: E3176. doi: 10.3390/ijms19103176. Review.

19.

Oxidative stress in hemodialysis: Causative mechanisms, clinical implications, and possible therapeutic interventions.

Liakopoulos V, Roumeliotis S, Zarogiannis S, Eleftheriadis T, Mertens PR.

Semin Dial. 2019 Jan;32(1):58-71. doi: 10.1111/sdi.12745. Epub 2018 Oct 4. Review.

PMID:
30288786
20.

Xanthine oxidase inhibitors may prevent or slow chronic kidney disease even in the absence of hyperuricemia.

Eleftheriadis T, Pissas G, Liakopoulos V, Stefanidis I.

Kidney Int. 2018 Oct;94(4):830-831. doi: 10.1016/j.kint.2018.06.019. No abstract available.

PMID:
30243322
21.

Uric acid and cellular and humoral alloimmunity.

Eleftheriadis T, Pissas G, Liakopoulos V, Stefanidis I.

J Heart Lung Transplant. 2018 Nov;37(11):1388. doi: 10.1016/j.healun.2018.08.004. Epub 2018 Aug 8. No abstract available.

PMID:
30241887
22.

Erratum.

Sarafidis PA, Loutradis C, Karpetas A, Tzanis G, Bikos A, Raptis V, Syrgkanis C, Liakopoulos V, Papagianni A, Bakris G, Parati G.

Nephrol Dial Transplant. 2018 Sep 19. doi: 10.1093/ndt/gfy311. [Epub ahead of print] No abstract available.

PMID:
30239875
23.

Hemodialysis-related changes in phenotypical features of monocytes.

Liakopoulos V, Jeron A, Shah A, Bruder D, Mertens PR, Gorny X.

Sci Rep. 2018 Sep 18;8(1):13964. doi: 10.1038/s41598-018-31889-2.

24.

The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.

Sarafidis PA, Loutradis C, Karpetas A, Tzanis G, Bikos A, Raptis V, Syrgkanis C, Liakopoulos V, Papagianni A, Bakris G, Parati G.

Nephrol Dial Transplant. 2019 Mar 1;34(3):515-523. doi: 10.1093/ndt/gfy247.

PMID:
30184172
25.

The effects of nebivolol and irbesartan on postdialysis and ambulatory blood pressure in patients with intradialytic hypertension: a randomized cross-over study.

Bikos A, Loutradis C, Angeloudi E, Karpetas A, Raptis V, Kalaitzidis R, Panagoutsos S, Pasadakis P, Balaskas I, Liakopoulos V, Papagianni A, Sarafidis PA.

J Hypertens. 2019 Feb;37(2):432-442. doi: 10.1097/HJH.0000000000001891.

PMID:
30063644
26.

SGLT-2 inhibitors in diabetic kidney disease: what lies behind their renoprotective properties?

Georgianos PI, Divani M, Eleftheriadis T, Mertens PR, Liakopoulos V.

Curr Med Chem. 2018 May 23. doi: 10.2174/0929867325666180524114033. [Epub ahead of print]

PMID:
29792136
27.

Oxidative Stress in Patients Undergoing Peritoneal Dialysis: A Current Review of the Literature.

Liakopoulos V, Roumeliotis S, Gorny X, Eleftheriadis T, Mertens PR.

Oxid Med Cell Longev. 2017 Dec 27;2017:3494867. doi: 10.1155/2017/3494867. eCollection 2017. Review.

28.

The sirtuin1 gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study.

Spoto B, Ntounousi E, Testa A, Liakopoulos V, D'Arrigo G, Tripepi G, Parlongo RM, Sanguedolce MC, Mallamaci F, Zoccali C.

J Hypertens. 2018 Aug;36(8):1705-1711. doi: 10.1097/HJH.0000000000001746.

PMID:
29702498
29.

IDO decreases glycolysis and glutaminolysis by activating GCN2K, while it increases fatty acid oxidation by activating AhR, thus preserving CD4+ T‑cell survival and proliferation.

Eleftheriadis T, Pissas G, Liakopoulos V, Stefanidis I.

Int J Mol Med. 2018 Jul;42(1):557-568. doi: 10.3892/ijmm.2018.3624. Epub 2018 Apr 16.

PMID:
29693118
30.

The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis.

Liakopoulos V, Stefanidis I, Mertens PR.

Am J Kidney Dis. 2018 Aug;72(2):309. doi: 10.1053/j.ajkd.2018.01.053. Epub 2018 Apr 16. No abstract available.

PMID:
29673724
31.

Arterial stiffness in end-stage renal disease-pathogenesis, clinical epidemiology, and therapeutic potentials.

Georgianos PI, Pikilidou MI, Liakopoulos V, Balaskas EV, Zebekakis PE.

Hypertens Res. 2018 May;41(5):309-319. doi: 10.1038/s41440-018-0025-5. Epub 2018 Mar 12. Review.

PMID:
29531291
32.
33.

Home blood pressure-guided antihypertensive therapy in chronic kidney disease: more data are needed.

Georgianos PI, Champidou E, Liakopoulos V, Balaskas EV, Zebekakis PE.

J Am Soc Hypertens. 2018 Apr;12(4):242-247. doi: 10.1016/j.jash.2018.02.002. Epub 2018 Feb 10.

PMID:
29459219
34.

Correction to: Tryptophan depletion under conditions that imitate insulin resistance enhances fatty acid oxidation and induces endothelial dysfunction through reactive oxygen species-dependent and independent pathways.

Eleftheriadis T, Pissas G, Sounidaki M, Antoniadi G, Rountas C, Liakopoulos V, Stefanidis I.

Mol Cell Biochem. 2018 Mar;440(1-2):221. doi: 10.1007/s11010-018-3277-0.

PMID:
29368094
35.

Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?

Duni A, Liakopoulos V, Rapsomanikis KP, Dounousi E.

Oxid Med Cell Longev. 2017;2017:9036450. doi: 10.1155/2017/9036450. Epub 2017 Nov 23. Review.

36.

Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.

Divani M, Georgianos PI, Didangelos T, Iliadis F, Makedou A, Hatzitolios A, Liakopoulos V, Grekas DM.

Am J Nephrol. 2018;47(1):21-29. doi: 10.1159/000485843. Epub 2017 Dec 22.

PMID:
29275415
37.

Comparison of the effect of the aerobic glycolysis inhibitor dichloroacetate and of the Krebs cycle inhibitor LW6 on cellular and humoral alloimmunity.

Eleftheriadis T, Pissas G, Mavropoulos A, Liakopoulos V, Stefanidis I.

Biomed Rep. 2017 Nov;7(5):439-444. doi: 10.3892/br.2017.980. Epub 2017 Sep 11.

38.

Oxidative Stress in Hemodialysis Patients: A Review of the Literature.

Liakopoulos V, Roumeliotis S, Gorny X, Dounousi E, Mertens PR.

Oxid Med Cell Longev. 2017;2017:3081856. doi: 10.1155/2017/3081856. Epub 2017 Sep 12. Review.

39.

Oxidative Stress and Acute Kidney Injury in Critical Illness: Pathophysiologic Mechanisms-Biomarkers-Interventions, and Future Perspectives.

Pavlakou P, Liakopoulos V, Eleftheriadis T, Mitsis M, Dounousi E.

Oxid Med Cell Longev. 2017;2017:6193694. doi: 10.1155/2017/6193694. Epub 2017 Sep 28. Review.

40.

Blood pressure and target-organ damage in hemodialysis: but which blood pressure?

Georgianos PI, Vaios V, Liakopoulos V, Zebekakis PE.

J Hypertens. 2017 Dec;35(12):2552-2553. doi: 10.1097/HJH.0000000000001553. No abstract available.

PMID:
29095236
41.

Allopurinol protects human glomerular endothelial cells from high glucose-induced reactive oxygen species generation, p53 overexpression and endothelial dysfunction.

Eleftheriadis T, Pissas G, Antoniadi G, Liakopoulos V, Stefanidis I.

Int Urol Nephrol. 2018 Jan;50(1):179-186. doi: 10.1007/s11255-017-1733-5. Epub 2017 Nov 1.

PMID:
29094329
42.

Urate crystals directly activate the T-cell receptor complex and induce T-cell proliferation.

Eleftheriadis T, Pissas G, Sounidaki M, Antoniadi G, Tsialtas I, Liakopoulos V, Stefanidis I.

Biomed Rep. 2017 Oct;7(4):365-369. doi: 10.3892/br.2017.960. Epub 2017 Aug 4.

43.

Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.

Georgianos PI, Liampas I, Kyriakou A, Vaios V, Raptis V, Savvidis N, Sioulis A, Liakopoulos V, Balaskas EV, Zebekakis PE.

Int Urol Nephrol. 2017 Dec;49(12):2217-2221. doi: 10.1007/s11255-017-1717-5. Epub 2017 Oct 11.

PMID:
29027620
44.

Late-onset Pompe's disease in a hemodialysis patient: A first case report.

Eleftheriadis T, Makri P, Karakosta P, Pissas G, Liakopoulos V, Michelakakis H, Hadjigeorgiou GM, Stefanidis I.

Hemodial Int. 2018 Apr;22(2):E23-E25. doi: 10.1111/hdi.12617. Epub 2017 Oct 3.

PMID:
28972689
45.

Single-Nephron Glomerular Filtration Rate in Healthy Adults.

Zarogiannis SG, Liakopoulos V, Schmitt CP.

N Engl J Med. 2017 Sep 21;377(12):1203. doi: 10.1056/NEJMc1709128. No abstract available.

PMID:
28930504
46.

Blood pressure variability is increasing from the first to the second day of the interdialytic interval in hemodialysis patients.

Karpetas A, Loutradis C, Bikos A, Tzanis G, Koutroumpas G, Lazaridis AA, Mavromatidis K, Liakopoulos V, Papagianni A, Zebekakis P, Ruilope LM, Parati G, Sarafidis PA.

J Hypertens. 2017 Dec;35(12):2517-2526. doi: 10.1097/HJH.0000000000001478.

PMID:
28806350
47.

Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study.

Liakopoulos V, Franzén S, Svensson AM, Zethelius B, Ottosson J, Näslund I, Gudbjörnsdottir S, Eliasson B.

BMJ Open Diabetes Res Care. 2017 Jun 14;5(1):e000386. doi: 10.1136/bmjdrc-2016-000386. eCollection 2017.

48.

Quiz: Nine Years of Persistent, Disabling Foot Pain in a Kidney Transplant Recipient.

Eleftheriadis T, Rountas C, Vlassis S, Karagiorgas G, Pissas G, Liakopoulos V, Stefanidis I.

Am J Kidney Dis. 2017 Aug;70(2):A13-A15. doi: 10.1053/j.ajkd.2017.04.015. No abstract available.

PMID:
28739127
49.

A comparative analysis between proteasome and immunoproteasome inhibition in cellular and humoral alloimmunity.

Eleftheriadis T, Pissas G, Antoniadi G, Liakopoulos V, Stefanidis I.

Int Immunopharmacol. 2017 Sep;50:48-54. doi: 10.1016/j.intimp.2017.06.009. Epub 2017 Jun 16.

PMID:
28628770
50.

Peritoneal dialysis-related infections recommendations: 2016 update. What is new?

Liakopoulos V, Nikitidou O, Kalathas T, Roumeliotis S, Salmas M, Eleftheriadis T.

Int Urol Nephrol. 2017 Dec;49(12):2177-2184. doi: 10.1007/s11255-017-1632-9. Epub 2017 Jun 1. Review.

PMID:
28573488

Supplemental Content

Loading ...
Support Center